company

VESTFOLD TERAPIRIDNING AS

3175 RAMNES

Return on Equity
230,56 %
Current Ratio
0,53
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue474 000
Net Income−83 000
Total Assets235 000
Total Equity−36 000
Income (NOK)2022
Revenue474 000
Expenditure557 000
Operating Profit−84 000
Financial Income1 000
Financial Costs0
Financial Balance1 000
Earnings Before Tax−83 000
Tax0
Net Income−83 000
Balance (NOK)2022
Total Fixed Assets92 000
Total Current Assets144 000
Total Assets235 000
Total Retained Equity−57 000
Total Equity−36 000
Total Long-Term Debt0
Total Current Debt271 000
Total Equity and Debt235 000
Cash flow (NOK)2022
Sales Income474 000
Other Income0
Revenue474 000
Cost of Goods Sold89 000
Salary Costs159 000
Depreciation8 000
Impairment0
Expenditure557 000
Operating Profit−84 000
Financial Income1 000
Financial Costs0
Financial Balance1 000
Dividends0
Net Income−83 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures92 000
Total Tangible Assets92 000
Total Fiancial Fixed Assets0
Total Fixed Assets92 000
Stock0
Total Investments0
Cash, Bank15 000
Total Current Assets144 000
Total Assets235 000
Total Equity−36 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors52 000
Unpaid Taxes12 000
Dividends0
Other Current Debt207 000
Total Current Debt271 000
Total Equity and Debt235 000
Financial indicators2022
Return on Equity230,56 %
Debt-to-Equity Ratio−0
Operating Profit Margin−17,72 %
Current Ratio0,53
Quick Ratio0,53
Equity Ratio−0,15
Gross Profit Margin81,22 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English